Relationship between hypoalbuminemia, hyperlipidemia and renal severity in patients with lupus nephritis: a prospective study

被引:20
作者
Sui, Manshu [1 ]
Jia, Xibei [1 ]
Yu, Chengyuan [2 ]
Guo, Xiaofang [1 ]
Liu, Xiaogang [1 ]
Ji, Ying [1 ]
Mu, Suhong [1 ]
Wu, Hongchi [1 ]
Xie, Rujuan [1 ]
机构
[1] Harbin Med Univ, Affiliated Hosp 1, Dept Nephrol, Harbin 150001, Peoples R China
[2] Harbin Med Univ, Affiliated Hosp 1, Dept Cardiol, Harbin 150001, Peoples R China
基金
中国国家自然科学基金;
关键词
hypoalbuminemia; hyperlipidemia; activity; renal damage; systemic lupus erythematosus; DIFFUSE PROLIFERATIVE GLOMERULONEPHRITIS; CHRONIC KIDNEY-DISEASE; ANTI-DNA ANTIBODIES; SLE PATIENTS; ERYTHEMATOSUS; PREDICTORS; MORTALITY; CLASSIFICATION; DYSLIPIDEMIA; EPIDEMIOLOGY;
D O I
10.5114/ceji.2014.43730
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Aim of the study: The purpose is to evaluate the relationship between hypoalbuminemia, hyperlipidemia, nephrotic and renal severity in patients with lupus nephritis. Material and methods: Autoantibodies and serological parameters were measured and analyzed in 429 patients with lupus nephritis in a single centre. Results: The prevalence for anti-dsDNA, anti-nucleosome and anti-histone was higher in the nephrotic syndrome (NS) patients than that in non-NS patients (p < 0.0001 for all comparisons). The NS patients had a higher proportion of diffuse proliferative renal lesions (69.05%) and membranous lesions (68.00%). Serum total cholesterol and albumin levels were associated with activity and severity of renal disease. The levels of proteinuria and serum albumin were positively correlated with activity and chronicity index (p < 0.001 for all correlations). The incidence of a poor renal outcome (p = 0.0461) in the NS patients was significantly increased. On the other hand, the remission rate (p = 0.0002) was significantly reduced and recurrence rate (p = 0.0027) was significantly increased in NS patients. Conclusions: This paper highlights that nephrotic-range proteinuria, elevated total cholesterol level and decreased serum albumin levels may reflect the activity and severity of renal damage in SLE patients.
引用
收藏
页码:243 / 252
页数:10
相关论文
共 29 条
[1]   Predictors of mortality and end stage renal disease in Saudi patients with lupus nephritis [J].
Al Durahim, H. ;
Al Ghamdi, G. ;
Al Seraya, A. ;
Alkhiari, R. ;
Al Sayyari, A. .
LUPUS, 2011, 20 (12) :1329-1335
[2]   EULAR recommendations for the management of systemic lupus erythematosus. Report of a task force of the EULAR standing committee for international clinical studies including therapeutics [J].
Bertsias, G. ;
Ioannidis, J. P. A. ;
Boletis, J. ;
Bombardieri, S. ;
Cervera, R. ;
Dostal, C. ;
Font, J. ;
Gilboe, I. M. ;
Houssiau, F. ;
Huizinga, T. ;
Isenberg, D. ;
Kallenberg, C. G. M. ;
Khamashta, M. ;
Piette, J. C. ;
Schneider, M. ;
Smolen, J. ;
Sturfelt, G. ;
Tincani, A. ;
van Vollenhoven, R. ;
Gordon, C. ;
Boumpas, D. T. .
ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (02) :195-205
[3]   The complex nature of serum C3 and C4 as biomarkers of lupus renal flare [J].
Birmingham, D. J. ;
Irshaid, F. ;
Nagaraja, H. N. ;
Zou, X. ;
Tsao, B. P. ;
Wu, H. ;
Yu, C. Y. ;
Hebert, L. A. ;
Rovin, B. H. .
LUPUS, 2010, 19 (11) :1272-1280
[4]  
Burlingame Rufus W., 2002, Autoimmunity Reviews, V1, P321, DOI 10.1016/S1568-9972(02)00083-6
[5]   Dyslipidaemia in patients with lupus nephritis [J].
Chong, Yip Boon ;
Yap, Desmond Yh ;
Tang, Colin So ;
Chan, Tak Mao .
NEPHROLOGY, 2011, 16 (05) :511-517
[6]   Outcomes in African Americans and Hispanics with lupus nephritis [J].
Contreras, G. ;
Lenz, O. ;
Pardo, V. ;
Borja, E. ;
Cely, C. ;
Iqbal, K. ;
Nahar, N. ;
de la Cuesta, C. ;
Hurtado, A. ;
Fornoni, A. ;
Beltran-Garcia, L. ;
Asif, A. ;
Young, L. ;
Diego, J. ;
Zachariah, M. ;
Smith-Norwood, B. .
KIDNEY INTERNATIONAL, 2006, 69 (10) :1846-1851
[7]   Factors associated with poor outcomes in patients with lupus nephritis [J].
Contreras, G ;
Pardo, V ;
Cely, C ;
Borja, E ;
Hurtado, A ;
De La Cuesta, C ;
Iqbal, K ;
Lenz, O ;
Asif, A ;
Nahar, N ;
Leclerq, B ;
Leon, C ;
Schulman, I ;
Ramirez-Seijas, F ;
Paredes, A ;
Cepero, A ;
Khan, T ;
Pachon, F ;
Tozman, E ;
Barreto, G ;
Hoffman, D ;
Suarez, MA ;
Busse, JC ;
Esquenazi, M ;
Esquenazi, A ;
Mayol, LG ;
Estrada, HG .
LUPUS, 2005, 14 (11) :890-895
[8]   Long-Term Mortality and Renal Outcome in a Cohort of 100 Patients With Lupus Nephritis [J].
Faurschou, Mikkel ;
Dreyer, Lene ;
Kamper, Anne-Lise ;
Starklint, Henrik ;
Jacobsen, Soren .
ARTHRITIS CARE & RESEARCH, 2010, 62 (06) :873-880
[9]   Analysis of clinical manifestations and pathology of lupus nephritis: a retrospective review of 82 cases [J].
Guo, Qiaoyan ;
Lu, Xuehong ;
Miao, Lining ;
Wu, Man ;
Lu, Shan ;
Luo, Ping .
CLINICAL RHEUMATOLOGY, 2010, 29 (10) :1175-1180
[10]   A potential trigger of nephiritogenic anti-DNA antibodies in lupus nephritis [J].
Hirabayashi, Y. ;
Oka, Y. ;
Tada, M. ;
Takahashi, R. ;
Ishii, I. .
AUTOIMMUNITY, PT D: AUTOIMMUNE DISEASE, ANNUS MIRABILIS, 2007, 1108 :92-95